# CMML-Specific Extraction Updates

## üéØ **CRITICAL UPDATE: CMML-ONLY DATA EXTRACTION**

### **‚úÖ PROBLEM IDENTIFIED**
The user correctly identified that the extraction was capturing data from mixed populations including:
- **MDS (Myelodysplastic Syndrome)**
- **MPS/MPD (Myeloproliferative Syndrome/Disorder)**
- **CMML (Chronic Myelomonocytic Leukemia)**

**Only CMML-specific data is needed for the analysis.**

## üîß **SOLUTIONS IMPLEMENTED**

### **1. Enhanced Azacitidine Extraction (`extract_clinical_efficacy_enhanced.py`)**
**Updated with CMML-specific prompts:**

#### **CMML-Specific Data Verification**
- Study must include CMML patients specifically
- Look for: "CMML", "chronic myelomonocytic leukemia", "CMML patients"
- If study only mentions MDS or MPS/MPD without CMML, mark as no efficacy data
- If study includes mixed populations, extract only CMML-specific data when available

#### **CMML-Only Metrics Extraction**
- **Efficacy Metrics**: CMML patients only
- **Survival Metrics**: CMML patients only  
- **Therapy Duration**: CMML patients only
- **Adverse Events**: CMML patients only
- **Patient Data**: CMML patients specifically

#### **Critical Rules Added**
- ONLY extract data if CMML patients are specifically mentioned
- If study only has MDS or MPS/MPD data without CMML, mark has_efficacy_data as false
- If study has mixed population, extract CMML-specific data when available
- If CMML data is not separately reported, mark as no efficacy data

### **2. Decitabine Extraction (`extract_decitabine_efficacy.py`)**
**Updated with identical CMML-specific prompts:**

#### **Same CMML-Specific Verification**
- Study must include CMML patients specifically
- Look for: "CMML", "chronic myelomonocytic leukemia", "CMML patients"
- If study only mentions MDS or MPS/MPD without CMML, mark as no efficacy data

#### **CMML-Only Data Extraction**
- **Response Rates**: CMML patients only
- **Survival Metrics**: CMML patients only
- **Patient Numbers**: CMML patients specifically
- **Supporting Information**: CMML-specific quotes and summaries

## üìä **EXPECTED IMPACT**

### **Data Quality Improvements**
- **More Accurate**: Only CMML-specific data will be extracted
- **Better Filtering**: Studies without CMML patients will be properly excluded
- **Cleaner Analysis**: No contamination from MDS or MPS/MPD data

### **Statistical Accuracy**
- **Pure CMML Cohort**: All extracted data will be CMML-specific
- **Better Comparisons**: Accurate drug-to-drug comparisons within CMML
- **Reliable Results**: No mixed population bias

## üîÑ **CURRENT STATUS**

### **Enhanced Azacitidine Extraction**
- **Status**: Running with CMML-specific prompts
- **Progress**: Restarted with updated prompts
- **Expected**: Higher quality, CMML-only data

### **Decitabine Extraction**
- **Status**: Updated with CMML-specific prompts
- **Ready**: Can be started when azacitidine completes
- **Expected**: CMML-only data extraction

### **Hydroxyurea Extraction**
- **Status**: Will use same CMML-specific prompts
- **Ready**: Script prepared with CMML-specific extraction

## üìã **UPDATED EXTRACTION CRITERIA**

### **‚úÖ ACCEPTABLE STUDIES**
- Studies that specifically mention CMML patients
- Studies with CMML-specific outcome data
- Studies that separate CMML results from other conditions

### **‚ùå EXCLUDED STUDIES**
- Studies that only mention MDS without CMML
- Studies that only mention MPS/MPD without CMML
- Studies with mixed populations where CMML data is not separately reported

### **‚ö†Ô∏è CONDITIONAL STUDIES**
- Mixed population studies where CMML data is separately reported
- Studies that mention CMML but don't provide specific outcome data

## üéØ **BENEFITS OF CMML-SPECIFIC EXTRACTION**

### **1. Accurate Drug Efficacy**
- Pure CMML response rates
- CMML-specific survival data
- CMML-specific adverse events

### **2. Reliable Comparisons**
- Azacitidine vs Decitabine in CMML only
- No contamination from other conditions
- Clean statistical analysis

### **3. Clinical Relevance**
- Directly applicable to CMML treatment decisions
- No extrapolation from other conditions
- Evidence-based CMML-specific recommendations

## üìà **PROJECTED RESULTS**

### **After CMML-Specific Extraction**
- **Higher Quality Data**: Only CMML-specific outcomes
- **Better Statistical Power**: Pure CMML cohorts
- **More Reliable Conclusions**: No mixed population bias
- **Clinical Relevance**: Directly applicable to CMML treatment

### **Dashboard Updates**
- **Accurate Statistics**: CMML-only median/mean values
- **Reliable Comparisons**: Clean drug-to-drug analysis
- **Clinical Utility**: CMML-specific treatment insights

---

**Last Updated**: 2025-08-16 14:50:00
**Status**: CMML-specific extraction running, decitabine updated and ready
**Key Improvement**: Pure CMML data extraction, no contamination from MDS or MPS/MPD
